Pépite | Etude retrospective des patients atteints d’un carcinome bronchique non à petites cellules avec mutation BRAF V600E

(G) Proportion of tumor-derived ccfDNA and KRAS-mutated tumor- derived ccfDNA versus nontumor-derived ccfDNA expressed as the percentage of the total ccfDNA (derived from both mouse

[25] reported the good prognostic value of ERCC1 high-intensity (above median value) tumour immunostaining, and the predictive value for lower overall survival of high expression

Median simulated response rates by pembrolizumab dose spanning the observed range of NSCLC exposure (1000 simulated trials, each with 1000 patients). PD-L1 expression was

Solicitar ao Diretor-Geral que apresente ao Comitê Executivo, em sua Vigésima Quinta Reunião Ordinária, um relatório de andamento sobre a modernização da gestão

Ces résultats montrent la supériorité des αPD-1 sur la chimiothérapie standard en seconde ligne de traitement des CBNPC. Cependant, une part non négligeable de patients ne

Or, pour autant que nous pouvons le savoir, il semble qu'il s'agissait d'une rotonde recouverte d'un toit surmonté d'un acrotère où était sculpté le monogramme du

The realization of our goal consists in morphing a special strati- fied LD point set into a close approximation of a given stratified reference point set; thus adopting the

RECIST progression at first evaluation and ≥ two-fold increase in TGR between the REF and the EXP periods Death within three months of nivolumab initiation TGK ratio